Salivary biomarkers in oral cancer diagnosis: advancing conventional treatment strategies

Ankit Paul; Tarun Kumar Upadhyay; Adil Ali; Hemant Singh; Mohd Saeed; Farrukh Aqil

doi:10.1016/j.mmr.2026.100018

Your Location：

Home >

Browse articles >

Salivary biomarkers in oral cancer diagnosis: advancing conventional treatment strategies

REVIEW | Updated：2026-05-11

- Salivary biomarkers in oral cancer diagnosis: advancing conventional treatment strategies
- Salivary biomarkers in oral cancer diagnosis: advancing conventional treatment strategies
- 军事医学研究（英文） 2026年
- Affiliations：
  
  Department of Biotechnology, Parul Institute of Applied Sciences and Research and Development Cell, Parul University, Vadodara 391760, Gujarat, India
  Biological Sciences, Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab Emirates
  Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab Emirates
  Department of Biology, College of Science, University of Hail, PO BOX 2240, Hail, Saudi Arabia
  Department of Medicine, Brown Cancer Center, University of Louisville, Louisville, KY, 40202, USA
- Author bio：
  
  Tarun Kumar Upadhyay, tarun_bioinfo@yahoo.co.in; tarun.upadhyay35971@paruluniversity.ac.in
  *Corresponding authors: Farrukh Aqil, farrukh.aqil@louisville.edu;
- Funds：
  
  the Brown Cancer Center, CCII CoBRE Grant(P20GM135004);the Jewish Heritage Fund for Excellence Research Enhancement Grant Program(G7043)
- DOI：10.1016/j.mmr.2026.100018
  中图分类号：
- 收稿：2025-07-10，
  
  录用：2026-03-06，
  
  纸质出版：2026-04
- Accepted：
Scan QR Code
Ankit Paul, Tarun Kumar Upadhyay, Adil Ali, 等. Salivary biomarkers in oral cancer diagnosis: advancing conventional treatment strategies[J/OL]. 军事医学研究（英文）, 2026.

Paul A, Upadhyay TK, Ali A, Singh H, Saeed M, Aqil F. Salivary biomarkers in oral cancer diagnosis: advancing conventional treatment strategies. Mil Med Res. 2026;13(1):100018.
Ankit Paul, Tarun Kumar Upadhyay, Adil Ali, 等. Salivary biomarkers in oral cancer diagnosis: advancing conventional treatment strategies[J/OL]. 军事医学研究（英文）, 2026. DOI： 10.1016/j.mmr.2026.100018.

Paul A, Upadhyay TK, Ali A, Singh H, Saeed M, Aqil F. Salivary biomarkers in oral cancer diagnosis: advancing conventional treatment strategies. Mil Med Res. 2026;13(1):100018. DOI： 10.1016/j.mmr.2026.100018.

摘要

Abstract

Oral squamous cell carcinoma (OSCC) is a major global health challenge

with most cases being diagnosed at advanced stages. Traditional diagnostic methods are often invasive and costly

and can delay diagnosis. Saliva has emerged as a promising non-invasive source of biomarkers for OSCC detection. This highlights the need for accessible

non-invasive

and sensitive biomarkers for OSCC detection. This review critically evaluates the current status and future potential of salivary biomarkers in OSCC

with an emphasis on their diagnostic efficacy

sensitivity

specificity

clinical validation

and advantages over traditional serum- and plasma-based markers. Saliva is a promising liquid for biopsy due to its non-invasive collection and molecular richness. We summarize evidence on diverse salivary biomarkers

including microRNAs (miRNAs)

proteins

metabolites

circulating tumor cells (CTCs)

and circulating tumor DNA (ctDNA)

highlighting their dysregulation in OSCC and diagnostic utility. Particular emphasis is placed on CTCs

ctDNA

and miRNAs

which demonstrate stability in saliva and potential for early detection. We further discuss advances in next-generation sequencing

mass spectrometry

and artificial intelligence/machine learning that enable the development of biomarker panels with improved diagnostic accuracy over single markers. Despite challenges such as sample heterogeneity and the lack of standardized protocols

salivary biomarkers hold strong potential to transform OSCC care by enabling earlier detection

guiding personalized therapies

and supporting non-invasive disease monitoring. However

achieving methodological standardization

validating biomarkers across diverse cohorts

and integrating them into clinical workflows are imperative before their routine application in practice.

关键词

Keywords

references

Sarode G , Maniyar N , Sarode SC , Jafer M , Patil S , Awan KH , et al . Epidemiologic aspects of oral cancer . Dis Mon . 2020 ; 66 ( 12 ): 100988 .

Nokovitch L , Maquet C , Crampon F , Taihi I , Roussel LM , Obongo R , et al . Oral cavity squamous cell carcinoma risk factors: state of the art . J Clin Med . 2023 ; 12 ( 9 ): 3264 .

Johnson DE , Burtness B , Leemans CR , Lui VW , Bauman JE , Grandis JR , et al . Head and neck squamous cell carcinoma . Nat Rev Dis Primers . 2020 ; 6 ( 1 ): 92 .

Sung H , Ferlay J , Siegel RL , Laversanne M , Soerjomataram I , Jemal A , et al . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries . CA Cancer J Clin . 2021 ; 71 ( 3 ): 209 - 49 .

Jagadeesan D , Sathasivam KV , Fuloria NK , Balakrishnan V , Khor GH , Ravichandran M , et al . Comprehensive insights into oral squamous cell carcinoma: diagnosis, pathogenesis, and therapeutic advances . Pathol Res Pract . 2024 ; 261 : 155489 .

Ramachandran S . Oral cancer: recent breakthroughs in pathology and therapeutic approaches . Oral Oncol Rep . 2024 ; 12 : 100678 .

Warnakulasuriya S . Global epidemiology of oral and oropharyngeal cancer . Oral Oncol . 2009 ; 45 ( 4-5 ): 309 - 16 .

Ojeda D , Huber MA , Kerr AR . Oral potentially malignant disorders and oral cavity cancer . Dermatol Clin . 2020 ; 38 ( 4 ): 507 - 21 .

Abati S , Bramati C , Bondi S , Lissoni A , Trimarchi M . Oral cancer and precancer: a narrative review on the relevance of early diagnosis . Int. J Environ, Res. Public Health . 2020 ; 17 ( 24 ): 9160 .

Su YF , Chen YJ , Tsai FT , Li WC , Hsu ML , Wang DH , et al . Current insights into oral cancer diagnostics . Diagnostics . 2021 ; 11 ( 7 ): 1287 .

Kijowska J , Grzegorczyk J , Gliwa K , Jędras A , Sitarz M . Epidemiology, diagnostics, and therapy of oral cancer - update review . Cancers . 2024 ; 16 ( 18 ): 3156 .

Laura QM , Chow MD . Head and neck cancer . N Engl J Med . 2020 ; 382 ( 1 ): 60 - 72 .

González-Moles MÁ , Aguilar-Ruiz M , Ramos-García P . Challenges in the early diagnosis of oral cancer, evidence gaps and strategies for improvement: a scoping review of systematic reviews . Cancers . 2022 ; 14 ( 19 ): 4967 .

Gileva OS , Libik TV , Danilov KV . Oral precancerous lesions: problems of early detection and oral cancer prevention . AIP Conf. Proc . 2016 : 1760 ( 1 ): 020019 .

Albano D , Argo A , Bilello G , Cumbo E , Lupatelli M , Messina P , et al . Oral squamous cell carcinoma: features and medico‐legal implications of diagnostic omission . Case Rep Dent . 2024 ;( 1 ): 2578271 .

Khong B , Ferlito S , Quek S , Conte G , Ingrassia A , Lechien JR , et al . Past, present, and future diagnostic methods for the early noninvasive detection of oral premalignant lesions: a state of the art and systematic review . Ear Nose Throat J . 2024 : 1455613241245204 .

Lauritzen BB , Jensen JS , Grønhøj C , Wessel I , von Buchwald C . Impact of delay in diagnosis and treatment-initiation on disease stage and survival in oral cavity cancer: a systematic review . Acta Oncol . 2021 ; 60 ( 9 ): 1083 - 90 .

Tsai E , Walker B , Wu SC . Can oral cancer screening reduce late-stage diagnosis, treatment delay and mortality? A population-based study in Taiwan . BMJ Open . 2024 ; 14 ( 12 ): e086588 .

Wang S , Yang M , Li R , Bai J . Current advances in noninvasive methods for the diagnosis of oral squamous cell carcinoma: a review . Eur J Med Res . 2023 ; 28 ( 1 ): 53 .

González-Ruiz I , Ramos-García P , Ruiz-Avila I , Gonzalez-Moles MA . Early diagnosis of oral cancer: a complex polyhedral problem with a difficult solution . Cancers . 2023 ; 15 ( 13 ): 3270 .

Asthana S , Vohra P , Labani S . Association of smokeless tobacco with oral cancer: a review of systematic reviews . Tob Prev Cessat . 2019 ; 5 : 34 .

Menon A , Mutalik VS , Chen Y , Ponamgi SP , Peela S , Schroth RJ , et al . Beyond genetics: exploring lifestyle, microbiome, and social determinants in oral cancer development . Cancers . 2025 ; 17 ( 7 ): 1094 .

Khare M , Dewangan Y , Nayak T , Singh DK , Vibhakar V , Ramesh K , et al . Oral and esophageal cancer: incidence, prevalence and correlation in general Indian population: a retrospective study . J Pharm Bioallied Sci . 2021 ; 13 ( Suppl 1 ): S221 - 4 .

Adeoye J , Hui L , Tan JY , Koohi-Moghadam M , Choi SW , Thomson P , et al . Prognostic value of non-smoking, non-alcohol drinking status in oral cavity cancer . Clin Oral Investig . 2021 ; 25 ( 12 ): 6909 - 18 .

Huang DQ , Mathurin P , Cortez-Pinto H , Loomba R . Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors . Nat Rev Gastroenterol Hepatol . 2023 ; 20 ( 1 ): 37 - 49 .

Gunjal S , Pateel DGS , Yang YH , Doss JG , Bilal S , Maling TH , et al . An overview on betel quid and areca nut practice and control in selected Asian and South East Asian countries . Subst Use Misuse . 2020 ; 55 ( 9 ): 1533 - 44 .

Zhang P , Chua NQE , Dang S , Davis A , Chong KW , Prime SS , et al . Molecular mechanisms of malignant transformation of oral submucous fibrosis by different betel quid constituents – does fibroblast senescence play a role? . Int J Mol Sci . 2022 ; 23 ( 3 ): 1637 .

Mazurek AM , Jabłońska I , Kentnowski M , Kacorzyk U , Śnietura M , Rutkowski TW , et al . Pretreatment circulating HPV16 DNA viral load predicts risk of distant metastasis in patients with HPV16-positive oropharyngeal cancer . Cancers . 2024 ; 16 ( 6 ): 1163 .

Santacroce L , Di Cosola M , Bottalico L , Topi S , Charitos IA , Ballini A , et al . Focus on HPV infection and the molecular mechanisms of oral carcinogenesis . Viruses . 2021 ; 13 ( 4 ): 559 .

Pirmoradi Z , Nazari K , Shafiee N , Nikoukar N , Minoo S , Ghasemi H , et al . Oral cancer and HPV: review article . Asian Pac J Cancer Biol . 2024 ; 9 ( 1 ): 87 - 95 .

Rodríguez-Molinero J , Migueláñez-Medrán BD , Puente-Gutiérrez C , Delgado-Somolinos E , Martín Carreras-Presas C , Fernández-Farhall J , et al . Association between oral cancer and diet: an update . Nutrients . 2021 ; 13 ( 4 ): 1299 .

Ganguly S , Kumar J . Role of antioxidant vitamins and minerals from herbal source in the management of lifestyle diseases . In: Role of herbal medicines . Singapore : Springer Nature Singapore . 2024 ; p. 443 - 60 .

Bulanda S , Lau K , Nowak A , Łyko-Morawska D , Kotylak A , Janoszka B , et al . The risk of oral cancer and the high consumption of thermally processed meat containing mutagenic and carcinogenic compounds . Nutrients . 2024 ; 16 ( 7 ): 1084 .

Bugshan A , Farooq I . Oral squamous cell carcinoma: metastasis, potentially associated malignant disorders, etiology, and recent advancements in diagnosis . F1000Res . 2020 ; 9 : 229 .

Fatima J , Fatima E , Mehmood F , Ishtiaq I , Khan MA , Khurshid HM , et al . Comprehensive analysis of oral squamous cell carcinomas: clinical, epidemiological, and histopathological insights with a focus on prognostic factors and survival time . Cureus . 2024 ; 16 ( 2 ): e54394 .

Mishra R . Biomarkers of oral premalignant epithelial lesions for clinical application . Oral Oncol . 2012 ; 48 ( 7 ): 578 - 84 .

Louisy A , Humbert E , Samimi M . Oral lichen planus: an update on diagnosis and management . Am J Clin Dermatol . 2024 ; 25 ( 1 ): 35 - 53 .

Das R , Misra SR , Baskaran P , Mohanty N . Oral erythroplakia harbouring a squamous cell carcinoma . BMJ Case Rep . 2022 ; 15 ( 2 ): e247983 .

Qin X , Ning Y , Zhou L , Zhu Y . Oral submucous fibrosis: etiological mechanism, malignant transformation, therapeutic approaches and targets . Int J Mol Sci . 2023 ; 24 ( 5 ): 4992 .

Hankinson P , Mahmood H , Walsh H , Speight PM , Khurram SA . Demystifying oral epithelial dysplasia: a histological guide . Pathology . 2024 ; 56 ( 1 ): 11 - 23 .

Byrd DR , Brookland RK , Washington MK , Gershenwald JE , Compton CC , Hess KR , et al . AJCC Cancer Staging Manual . New York : Springer . 2017 ; 1024

de Sousa Cabral LG , Martins IM , de Abreu Paulo EP , Pomini KT , Poyet JL , Maria DA , et al . Molecular mechanisms in the carcinogenesis of oral squamous cell carcinoma: a literature review . Biomolecules . 2025 ; 15 ( 5 ): 621 .

Tyagi D , Singhal M , Gulati N , Jain A , Shetty DC . Evaluation of EGFR in prognostic characterization in histopathological variants of oral squamous cell carcinoma . J Cancer Res Ther . 2023 ; 19 ( Suppl 2 ): S743 - 6 .

Parvez A , Agarwal P , Prakash S , Singh AP , Gupta S . Study of cyclin D1 expression in squamous cell carcinoma of oral cavity . Indian J Otolaryngol Head Neck Surg . 2025 ; 77 ( 5 ): 2070 - 7 .

Polz A , Morshed K , Drop B , Polz-Dacewicz M . Could MMP3 and MMP9 serve as biomarkers in EBV-related oropharyngeal cancer? . Int J Mol Sci . 2024 ; 25 ( 5 ): 2561 .

Singh G , Pandey R , Anthony ER , Chandra S , Mehrotra D . Expression and bioinformatics analyses show HSP70 complements BCL2 action in oral carcinogenesis . J Oral Biol Craniofac Res . 2022 ; 12 ( 5 ): 599 - 603 .

Glathar AR , Oyelakin A , Nayak KB , Sosa J , Romano RA , Sinha S , et al . A systemic and integrated analysis of p63-driven regulatory networks in mouse oral squamous cell carcinoma . Cancers . 2023 ; 15 ( 2 ): 446 .

Marconi GD , Della Rocca Y , Fonticoli L , Melfi F , Rajan TS , Carradori S , et al . C-Myc expression in oral squamous cell carcinoma: molecular mechanisms in cell survival and cancer progression . Pharmaceuticals . 2022 ; 15 ( 7 ): 890 .

Nocini R , Vianini M , Girolami I , Calabrese L , Scarpa A , Martini M , et al . PD‐L1 in oral squamous cell carcinoma: a key biomarker from the laboratory to the bedside . Clin Exp Dent Res . 2022 ; 8 ( 3 ): 690 - 8 .

Xiao L , Li X , Cao P , Fei W , Zhou H , Tang N , et al . Interleukin-6-mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway . J Exp Clin Res . 2022 ; 41 ( 1 ): 166 .

Giri R , Hota SK , Sahu SK , Senapati U . Expression of TP53 in oral squamous cell carcinoma and its correlation with adverse histopathological features . J Cancer Res Ther . 2023 ; 19 ( 2 ): 278 - 82 .

Saxena P , Prasad S . Evaluation of p16 expression in oral and oropharyngeal squamous cell carcinoma . J Oral Maxillofac Pathol . 2022 ; 26 ( 3 ): 376 - 81 .

Liu M , Song H , Xing Z , Lu G , Li J , Chen D , et al . Correlation between PTEN gene polymorphism and oral squamous cell carcinoma . Oncol Lett . 2019 ; 18 ( 2 ): 1755 - 60 .

Kalaimani G , Rao UDK , Joshua E , Ranganathan K . E-cadherin expression in premalignant lesions, premalignant conditions, oral squamous cell carcinoma, and normal mucosa: an immunohistochemical study . Cureus . 2023 ; 15 ( 8 ): e44266 .

Kajiyama T , Serada S , Fujimoto M , Ohkawara T , Komori M , Hyodo M , et al . SOCS1 gene therapy for head and neck cancers: an experimental study . Anticancer Res . 2022 ; 42 ( 7 ): 3361 - 72 .

Li S , Peng Y , Panchenko AR . DNA methylation: precise modulation of chromatin structure and dynamics . Curr Opin Struct Biol . 2022 ; 75 : 102430 .

Cui SH , Hu XD , Yan Y . Wnt/β‐catenin signaling pathway participates in the effect of miR‐626 on oral squamous cell carcinoma by targeting RASSF4 . J Oral Pathol Med . 2021 ; 50 ( 10 ): 1005 - 17 .

Ai Y , Wu S , Zou C , Wei H . LINC00941 promotes oral squamous cell carcinoma progression via activating CAPRIN2 and canonical WNT/β‐catenin signaling pathway . J Cell Mol Med . 2020 ; 24 ( 18 ): 10512 - 24 .

Oliveira Alves MG , da Silva Miguel N , Ferreira CC , Alvarenga ER , Tonon BM , de Barros PP , et al . Expression of DNA repair genes in oral squamous cell carcinoma using reverse transcription-quantitative polymerase chain reaction . Oral Surg Oral Med Oral Pathol Oral Radiol . 2020 ; 130 ( 3 ): 298 - 305 .

Ukey S , Jain A , Dwivedi S , Vishnoi JR , Chugh A , Purohit P , et al . Global and promoter-specific hypermethylation of tumor suppressor genes P16, SOCS1, and SHP1 in oral squamous cell carcinoma and oral submucous fibrosis . J Cancer Res Ther . 2023 ; 19 ( Suppl 2 ): S551 - 9 .

Kumari S , Mishra S , Anand N , Hadi R , Rastogi M , Husain N , et al . Circulating free DNA integrity index and promoter methylation of tumor suppressor gene P16, DAPK, and RASSF1A as a biomarker for oropharyngeal squamous cell carcinoma . Pathol Res Pract . 2023 ; 246 : 154489 .

Mesgari H , Esmaelian S , Nasiri K , Ghasemzadeh S , Doroudgar P , Payandeh Z , et al . Epigenetic regulation in oral squamous cell carcinoma microenvironment: a comprehensive review . Cancers . 2023 ; 15 ( 23 ): 5600 .

Jensen GL , Axelrud G , Fink D , Hammonds K , Walker K , Volz M , et al . Improved local control in p16-negative oropharyngeal cancers with hypermethylated MGMT . Radiother Oncol . 2021 ; 157 : 234 - 40 .

Rajendran P , Prasad M , Ali EM , Sekar R , AlZahrani AM , Karobari MI , et al . Molecular insight into histone methylation as a novel target for oral squamous cell carcinoma: future hope in personalised medicine . J Cancer . 2025 ; 16 ( 5 ): 1575 .

Yang H , Jin X , Dan H , Chen Q . Histone modifications in oral squamous cell carcinoma and oral potentially malignant disorders . Oral Dis . 2020 ; 26 ( 4 ): 719 - 32 .

Lu Y , Yang J , Zhu J , Shu Y , Zou X , Ruan Q , et al . Advances in the histone acetylation modification in the oral squamous cell carcinoma . J Oncol . 2023 ; 2023 : 4616682 .

Chen IC , Chiang WF , Huang HH , Chen PF , Shen YY , Chiang HC , et al . Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis . Mol Cancer . 2014 ; 13 : 254 .

Shahhosseini A , Bourova-Flin E , Derakhshan S , Aminishakib P , Goudarzi A . High levels of histone H3 K27 acetylation and tri-methylation are associated with shorter survival in oral squamous cell carcinoma patients . Biomedicine (Taipei) . 2023 ; 13 ( 1 ): 22 .

Chen J , Tang S , Zheng Q , Li J , Jiang H , Lu H , et al . The competitive mechanism of EZH1 and EZH2 in promoting oral squamous cell carcinoma . Exp Cell Res . 2024 ; 436 ( 1 ): 113957 .

Shreya Reddy CS , Usman P P AS , Ganapathy DM , Kp A , Sekar D . MicroRNA-21 as a biomarker in terminal stage oral squamous cell carcinoma (OSCC) in the South Indian population . Oral Oncol Rep . 2024 ; 9 : 100139 .

Cheng Y , Li S , Gao L , Zhi K , Ren W . The molecular basis and therapeutic aspects of cisplatin resistance in oral squamous cell carcinoma . Front. Oncol . 2021 ; 11 : 761379 .

Ge X , Gao J , Sun QW , Wang CX , Deng W , Mao GY , et al . MiR‐34a inhibits the proliferation, migration, and invasion of oral squamous cell carcinoma by directly targeting SATB2 . J Cell Physiol . 2020 ; 235 ( 5 ): 4856 - 64 .

Ni YH , Huang XF , Wang ZY , Han W , Deng RZ , Mou YB , et al . Upregulation of a potential prognostic biomarker, miR-155, enhances cell proliferation in patients with oral squamous cell carcinoma . Oral Surg Oral Med Oral Pathol Oral Radiol . 2014 ; 117 ( 2 ): 227 - 33 .

Song J , Zhang N , Cao L , Xiao D , Ye X , Luo E , et al . Down-regulation of miR-200c associates with poor prognosis of oral squamous cell carcinoma . Int J Clin Oncol . 2020 ; 25 ( 6 ): 1072 - 8 .

Chamoli A , Gosavi AS , Shirwadkar UP , Wangdale KV , Behera SK , Kurrey NK , et al . Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics . Oral Oncol . 2021 ; 121 : 105451 .

Ahmed AA , Sborchia M , Bye H , Roman-Escorza M , Amar A , Henley-Smith R , et al . Mutation detection in saliva from oral cancer patients . Oral Oncol . 2024 ; 151 : 106717 .

Usman S , Jamal A , Teh MT , Waseem, A . Major molecular signaling pathways in oral cancer associated with therapeutic resistance . Front Oral Health . 2021 ; 1 : 603160 .

Chen C , Nelson LJ , Ávila MA , Cubero FJ . Mitogen-activated protein kinases (MAPKs) and cholangiocarcinoma: the missing link . Cells . 2019 ; 8 ( 10 ): 1172 .

Cheng Y , Chen J , Shi Y , Fang X , Tang Z . MAPK signaling pathway in oral squamous cell carcinoma: biological function and targeted therapy . Cancers . 2022 ; 14 ( 19 ): 4625 .

Morgos DT , Stefani C , Miricescu D , Greabu M , Stanciu S , Nica S , et al . Targeting PI3K/AKT/mTOR and MAPK signaling pathways in gastric cancer . Int J Mol Sci . 2024 ; 25 ( 3 ): 1848 .

Jha A , Alam M , Kashyap T , Nath N , Kumari A , Pramanik KK , et al . Crosstalk between PD-L1 and Jak2-Stat3/MAPK-AP1 signaling promotes oral cancer progression, invasion, and therapy resistance . Int Immunopharmacol . 2023 ; 124 ( Pt A ): 110894 .

Yu F , Yu C , Li F , Zuo Y , Wang Y , Yao L , et al . Wnt/β-catenin signaling in cancers and targeted therapies . Signal Transduct Target Ther . 2021 ; 6 ( 1 ): 307 .

Xie J , Huang L , Lu YG , Zheng DL . Roles of the Wnt signaling pathway in head and neck squamous cell carcinoma . Front. Mol. Biosci . 2021 ; 7 : 590912 .

Wang Y , Cao Z , Liu F , Ou Y . Clinical significance of activated Wnt/β-catenin signaling in apoptosis inhibition of oral cancer . Open Life Sci . 2021 ; 16 ( 1 ): 1045 - 52 .

Velázquez DM , Castañeda-Patlán MC , Robles-Flores M . Dishevelled stability is positively regulated by PKCζ-mediated phosphorylation induced by Wnt agonists . Cell Signal . 2017 ; 35 : 107 - 17 .

Farooqi AA , Shu CW , Huang HW , Wang HR , Chang YT , Fayyaz S , et al . TRAIL, Wnt, sonic hedgehog, TGFβ, and miRNA signalings are potential targets for oral cancer therapy . Int J Mol Sci . 2017 ; 18 ( 7 ): 1523 .

Psyrri A , Kotoula V , Fountzilas E , Alexopoulou Z , Bobos M , Televantou D , et al . Prognostic significance of the Wnt pathway in squamous cell laryngeal cancer . Oral Oncol . 2014 ; 50 ( 4 ): 298 - 305 .

Prgomet Z , Axelsson L , Lindberg P , Andersson T . Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression . J Oral Pathol Med . 2015 ; 44 ( 10 ): 776 - 84 .

Lien WH , Fuchs E . Wnt some lose some: transcriptional governance of stem cells by Wnt/β-catenin signaling . Genes Dev . 2014 ; 28 ( 14 ): 1517 - 32 .

Glaviano A , Foo ASC , Lam HY , Yap KC , Jacot W , Jones RH , et al . PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer . Mol Cancer . 2023 ; 22 ( 1 ): 138 .

Shi Q , Xue C , Zeng Y , Yuan X , Chu Q , Jiang S , et al . Notch signaling pathway in cancer: from mechanistic insights to targeted therapies . Signal Transduct Target Ther . 2024 ; 9 ( 1 ): 128 .

Nigam K , Srivastav RK . Notch signaling in oral pre-cancer and oral cancer . Med Oncol . 2021 ; 38 ( 12 ): 139 .

Porcheri C , Meisel CT , Mitsiadis T . Multifactorial contribution of Notch signaling in head and neck squamous cell carcinoma . Int. J. Mol. Sci . 2019 ; 20 ( 6 ): 1520 .

Guo Y , Xu T , Chai Y , Chen F . TGF-β signaling in progression of oral cancer . Int J Mol Sci . 2023 ; 24 ( 12 ): 10263 .

Ibi H , Takahashi K , Harada H , Watabe T , Podyma-Inoue KA . Transforming growth factor-β signals promote progression of squamous cell carcinoma by inducing epithelial-mesenchymal transition and angiogenesis . Biochem Biophys Res Commun . 2024 ; 714 : 149965 .

Ganesh A , Usman PA , Thomas P , Ganapathy DM , Sekar D . Expression analysis of transforming growth factor beta (TGF-β) in oral squamous cell carcinoma . Oral Oncol Rep . 2024 ; 9 : 100195 .

Wang X , Sun W , Bai J , Ma L , Yu Y , Geng J , et al . Growth inhibition induced by transforming growth factor-β1 in human oral squamous cell carcinoma . Mol Biol Rep . 2009 ; 36 ( 5 ): 861 - 9 .

Paterson IC , Matthews JB , Huntley S , Robinson CM , Fahey M , Parkinson EK , et al . Decreased expression of TGF‐β cell surface receptors during progression of human oral squamous cell carcinoma . J Pathol . 2001 ; 193 ( 4 ): 458 - 67 .

James AW , Bhat HM , Yousuf S , Jan M , Rehman MU , Rashid SM . TGF-β signaling pathway and its therapeutic role in cancers . In: cell signaling pathways and their therapeutic implication . Singapore : Springer Nature Singapore . 2025 ; p. 321 - 55 .

Marques AEM , Elias ST , Porporatti AL , Castilho RM , Squarize CH , De Luca Canto G , et al . mTOR pathway protein immunoexpression as a prognostic factor for survival in head and neck cancer patients: a systematic review and meta‐analysis . J Oral Pathol Med . 2016 ; 45 ( 5 ): 319 - 28 .

Zhao Y , Yu D , Li H , Nie P , Zhu Y , Liu S , et al . Cyclin D1 overexpression is associated with poor clinicopathological outcome and survival in oral squamous cell carcinoma in Asian populations: insights from a meta-analysis . PLoS One . 2014 ; 9 ( 3 ): e93210 .

Klosek SK , Nakashiro KI , Hara S , Li C , Shintani S , Hamakawa H . Constitutive activation of Stat3 correlates with increased expression of the c-Met/HGF receptor in oral squamous cell carcinoma . Oncol Rep . 2004 ; 12 ( 2 ): 293 - 6 .

Zhang M , Li J , Wang L , Tian Z , Zhang P , Xu Q , et al . Prognostic significance of p21, p27, and survivin protein expression in patients with oral squamous cell carcinoma . Oncol Lett . 2013 ; 6 ( 2 ): 381 - 6 .

Padhi SS , Roy S , Kar M , Saha A , Roy S , Adhya A , et al . Role of CDKN2A/p16 expression in the prognostication of oral squamous cell carcinoma . Oncol Rep . 2017 ; 73 : 27 - 35 .

Zhao J , Chi J , Gao M , Zhi J , Li Y , Zheng X . Loss of PTEN expression is associated with high microRNA 24 level and poor prognosis in patients with tongue squamous cell carcinoma . J Oral Maxillofac Surg . 2017 ; 75 ( 7 ): 1449.e1 - 8 .

Pfeffer CM , Singh AT . Apoptosis: a target for anticancer therapy . Int J Mol Sci . 2018 ; 19 ( 2 ): 448 .

Kato K , Kawashiri S , Yoshizawa K , Kitahara H , Yamamoto E . Apoptosis‐associated markers and clinical outcome in human oral squamous cell carcinomas . J Oral Pathol Med . 2008 ; 37 ( 6 ): 364 - 71 .

Camisasca DR , Honorato J , Bernardo V , da Silva LE , da Fonseca EC , de Faria PA , et al . Expression of Bcl-2 family proteins and associated clinicopathologic factors predict survival outcome in patients with oral squamous cell carcinoma . Oral Oncol . 2009 ; 45 ( 3 ): 225 - 33 .

Xie S , Xu H , Shan X , Liu B , Wang K , Cai Z . Clinicopathological and prognostic significance of survivin expression in patients with oral squamous cell carcinoma: evidence from a meta-analysis . PLoS One . 2015 ; 10 ( 2 ): e0116517 .

Liu S , Shi L , Yang X , Ye D , Wang T , Dong C , et al . Nuclear survivin promoted by acetylation is associated with the aggressive phenotype of oral squamous cell carcinoma . Cell Cycle . 2017 ; 16 ( 9 ): 894 - 902 .

Nagata M , Nakayama H , Tanaka T , Yoshida R , Yoshitake Y , Fukuma D , et al . Overexpression of cIAP2 contributes to 5-FU resistance and a poor prognosis in oral squamous cell carcinoma . Br J Cancer . 2011 ; 105 ( 9 ): 1322 - 30 .

Benhamou Y , Picco V , Raybaud H , Sudaka A , Chamorey E , Brolih S , et al . Telomeric repeat-binding factor 2: a marker for survival and anti-EGFR efficacy in oral carcinoma . Oncotarget . 2016 ; 7 ( 28 ): 44236 .

Zhao Z , Ge J , Sun Y , Tian L , Lu J , Liu M , et al . Is E-cadherin immunoexpression a prognostic factor for head and neck squamous cell carcinoma (HNSCC)? A systematic review and meta-analysis . Oral Oncol . 2012 ; 48 ( 9 ): 761 - 7 .

Pu Y , Wang L , Wu H , Feng Z , Wang Y , Guo C . High MMP-21 expression in metastatic lymph nodes predicts unfavorable overall survival for oral squamous cell carcinoma patients with lymphatic metastasis . Oncol Rep . 2014 ; 31 ( 6 ): 2644 - 50 .

Vincent-Chong VK , Salahshourifar I , Karen-Ng LP , Siow MY , Kallarakkal TG , Ramanathan A , et al . Overexpression of MMP13 is associated with clinical outcomes and poor prognosis in oral squamous cell carcinoma . ScientificWorldJournal . 2014 ; 2014 : 897523 .

Jiang T , Xie P , Liu H . Circulating anti-matrix metalloproteinase-7 antibodies may be a potential biomarker for oral squamous cell carcinoma . J Oral Maxillofac Surg . 2016 ; 74 ( 3 ): 650 - 7 .

Hsin CH , Chou YE , Yang SF , Su SC , Chuang YT , Lin SH , et al . MMP-11 promoted the oral cancer migration and Fak/Src activation . Oncotarget . 2017 ; 8 ( 20 ): 32783 .

Liu S , Liu L , Ye W , Ye D , Wang T , Guo W , et al . High vimentin expression associated with lymph node metastasis and predicted a poor prognosis in oral squamous cell carcinoma . Sci Rep . 2016 ; 6 ( 1 ): 38834 .

Sasahira T , Kirita T , Kurihara M , Yamamoto K , Bhawal UK , Bosserhoff AK , et al . MIA-dependent angiogenesis and lymphangiogenesis are closely associated with progression, nodal metastasis and poor prognosis in tongue squamous cell carcinoma . Eur J Cancer . 2010 ; 46 ( 12 ): 2285 - 94 .

Sasahira T , Bosserhoff AK , Kirita T . The importance of melanoma inhibitory activity gene family in the tumor progression of oral cancer . Pathol Int . 2018 ; 68 ( 5 ): 278 - 86 .

Chen C , Zhang Y , Loomis MM , Upton MP , Lohavanichbutr P , Houck JR , et al . Genome-wide loss of heterozygosity and DNA copy number aberration in HPV-negative oral squamous cell carcinoma and their associations with disease-specific survival . PLoS One . 2015 ; 10 ( 8 ): e0135074 .

Kurihara Y , Hatori M , Ando Y , Ito D , Toyoshima T , Tanaka M , et al . Inhibition of cyclooxygenase-2 suppresses the invasiveness of oral squamous cell carcinoma cell lines via down-regulation of matrix metalloproteinase-2 production and activation . Clin Exp Metastasis . 2009 ; 26 ( 5 ): 425 - 32 .

Jinno T , Kawano S , Maruse Y , Matsubara R , Goto Y , Sakamoto T , et al . Increased expression of interleukin-6 predicts poor response to chemoradiotherapy and unfavorable prognosis in oral squamous cell carcinoma . Oncol Rep . 2015 ; 33 ( 5 ): 2161 - 8 .

Chen J , Zhou J , Lu J , Xiong H , Shi X , Gong L . Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysis . BMC Cancer . 2014 ; 14 : 15 .

Ferrari E , Pezzi ME , Cassi D , Pertinhez TA , Spisni A , Meleti M , et al . Salivary cytokines as biomarkers for oral squamous cell carcinoma: a systematic review . Int J Mol Sci . 2021 ; 22 ( 13 ): 6795 .

Alves AM , Diel LF , Lamers ML . Macrophages and prognosis of oral squamous cell carcinoma: a systematic review . J Oral Pathol Med . 2018 ; 47 ( 5 ): 460 - 7 .

Maruse Y , Kawano S , Jinno T , Matsubara R , Goto Y , Kaneko N , et al . Significant association of increased PD-L1 and PD-1 expression with nodal metastasis and a poor prognosis in oral squamous cell carcinoma . Int J Oral Maxillofac Surg . 2018 ; 47 ( 7 ): 836 - 45 .

Kunkel M , Moergel M , Stockinger M , Jeong JH , Fritz G , Lehr HA , et al . Overexpression of GLUT-1 is associated with resistance to radiotherapy and adverse prognosis in squamous cell carcinoma of the oral cavity . Oral Oncol . 2007 ; 43 ( 8 ): 796 - 803 .

Shimanishi M , Ogi K , Sogabe Y , Kaneko T , Dehari H , Miyazaki A , et al . Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia . J Oral Pathol Med . 2013 ; 42 ( 5 ): 382 - 8 .

Zhu GQ , Tang YL , Li L , Zheng M , Jiang J , Li XY , et al . Hypoxia inducible factor 1α and hypoxia inducible factor 2α play distinct and functionally overlapping roles in oral squamous cell carcinoma . Clin Cancer Res . 2010 ; 16 ( 19 ): 4732 - 41 .

Kristiansen G , Sammar M , Altevogt P . Tumour biological aspects of CD24, a mucin-like adhesion molecule . J Mol Histol . 2004 ; 35 ( 3 ): 255 - 62 .

Marei HE . Epigenetic regulators in cancer therapy and progression . NPJ Precis Oncol . 2025 ; 9 ( 1 ): 1 - 8 .

Hsiao JR , Chang CC , Lee WT , Huang CC , Ou CY , Tsai ST , et al . The interplay between oral microbiome, lifestyle factors and genetic polymorphisms in the risk of oral squamous cell carcinoma . Carcinogenesis . 2018 ; 39 ( 6 ): 778 - 87 .

Kavarthapu A , Gurumoorthy K . Linking chronic periodontitis and oral cancer: a review . Oral Oncol . 2021 ; 121 : 105375 .

Campo-Trapero J , Cano-Sánchez J , Palacios-Sánchez B , Llamas-Martínez S , Lo Muzio L , Bascones-Martínez A , et al . Cellular senescence in oral cancer and precancer and treatment implications: a review . Acta Oncol . 2008 ; 47 ( 8 ): 1464 - 74 .

Thiery J . Modulation of the antitumor immune response by cancer-associated fibroblasts: mechanisms and targeting strategies to hamper their immunosuppressive functions . Explor Target Antitumor Ther . 2022 ; 3 ( 5 ): 598 - 629 .

Zhang H , Yue X , Chen Z , Liu C , Wu W , Zhang N , et al . Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials . Mol Cancer . 2023 ; 22 ( 1 ): 159 .

Heide J , Bilecz AJ , Patnaik S , Allega MF , Donle L , Yang K , et al . NNMT inhibition in cancer-associated fibroblasts restores antitumour immunity . Nature . 2025 ; 645 : 1051 - 9 .

Gan M , Liu N , Li W , Chen M , Bai Z , Liu D , et al . Metabolic targeting of regulatory T cells in oral squamous cell carcinoma: new horizons in immunotherapy . Mol Cancer . 2024 ; 23 ( 1 ): 273 .

Psyrri A , Gkotzamanidou M , Papaxoinis G , Krikoni L , Economopoulou P , Kotsantis I , et al . The DNA damage response network in the treatment of head and neck squamous cell carcinoma . ESMO Open . 2021 ; 6 ( 2 ): 100075 .

Pai S , Yadav VK , Kuo KT , Pikatan NW , Lin CS , Chien MH , et al . PDK1 inhibitor BX795 improves cisplatin and radio-efficacy in oral squamous cell carcinoma by downregulating the PDK1/CD47/Akt-mediated glycolysis signaling pathway . Int J Mol Sci . 2021 ; 22 ( 21 ): 11492 .

Atashi F , Vahed N , Emamverdizadeh P , Fattahi S , Paya L . Drug resistance against 5-fluorouracil and cisplatin in the treatment of head and neck squamous cell carcinoma: a systematic review . J Dent Res Dent Clin Dent Prospects . 2021 ; 15 ( 3 ): 219 - 25 .

Peng J , Cui Y , Xu S , Wu X , Huang Y , Zhou W , et al . Altered glycolysis results in drug-resistant in clinical tumor therapy . Oncol Lett . 2021 ; 21 ( 5 ): 369 .

Bramati C , Abati S , Bondi S , Lissoni A , Arrigoni G , Filipello F , et al . Early diagnosis of oral squamous cell carcinoma may ensure better prognosis: a case series . Clin Case Rep . 2021 ; 9 ( 10 ): e05004 .

Sankaranarayanan R , Ramadas K , Thomas G , Muwonge R , Thara S , Mathew B , et al . Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial . Lancet . 2005 ; 365 ( 9475 ): 1927 - 33 .

Sankaranarayanan R , Ramadas K , Thara S , Muwonge R , Thomas G , Anju G , et al . Long term effect of visual screening on oral cancer incidence and mortality in a randomized trial in Kerala, India . Oral Oncol . 2013 ; 49 ( 4 ): 314 - 21 .

Warnakulasuriya S , Kerr AR . Oral cancer screening: past, present, and future . J Dent Res . 2021 ; 100 ( 12 ): 1313 - 20 .

Khanna D , Mishra A , Birur P , Shruti T , Gurushanth K , Mukhia N , et al . A prospective study on diagnostic accuracy of technology-enabled early detection of oral cancer and epidemiology of tobacco and other substances use in rural India . Cancer . 2025 ; 131 ( 1 ): e35702 .

Oswal K , Barman S , Kerr AR , Zaman M , Patowary J , Barali DD , et al . Oral cancer risk stratification: a cross‐sectional population‐based screening study in Northeast India . Int J Cancer . 2025 ; 158 ( 6 ): 1517 - 27 .

Padmanabhan G , Narayan M , Krishnan R . Recent diagnostic aids in oral squamous cell carcinoma – a detailed review . Oral Oncol Rep . 2024 ; 10 : 100323 .

Martin IC , Kerawala CJ , Reed M . The application of toluidine blue as a diagnostic adjunct in the detection of epithelial dysplasia . Oral Surg Oral Med Oral Pathol Oral Radiol Endod . 1998 ; 85 ( 4 ): 444 - 6 .

Gandolfo S , Pentenero M , Broccoletti R , Pagano M , Carrozzo M , Scully C , et al . Toluidine blue uptake in potentially malignant oral lesions in vivo : clinical and histological assessment . Oral Oncol . 2006 ; 42 ( 1 ): 88 - 94 .

Mashberg A , Samit A . Early diagnosis of asymptomatic oral and oropharyngeal squamous cancers . CA Cancer J Clin . 1995 ; 45 ( 6 ): 328 - 51 .

Ogden GR , Cowpe JG , Wight AJ . Oral exfoliative cytology: review of methods of assessment . J Oral Pathol Med . 1997 ; 26 ( 5 ): 201 - 5 .

Pérez-Sayáns M , Somoza-Martín JM , Barros-Angueira F , Reboiras-López MD , Gándara-Vila P , Rey JG , et al . Exfoliative cytology for diagnosing oral cancer . Biotech Histochem . 2010 ; 85 ( 3 ): 177 - 87 .

Kujan O , Desai M , Sargent A , Bailey A , Turner A , Sloan P , et al . Potential applications of oral brush cytology with liquid-based technology: results from a cohort of normal oral mucosa . Oral Oncol . 2006 ; 42 ( 8 ): 810 - 8 .

Navone R , Pentenero M , Rostan I , Burlo P , Marsico A , Broccoletti R , et al . Oral potentially malignant lesions: first-level microhistological diagnosis from tissue fragments sampled in liquid-based diagnostic cytology . J Oral Pathol Med . 2008 ; 37 ( 6 ): 358 - 63 .

Hayama FH , Motta AC , Silva Ade P , Migliari DA . Liquid-based preparations versus conventional cytology: specimen adequacy and diagnostic agreement in oral lesions . Med Oral Patol Oral Cir Bucal . 2005 ; 10 ( 2 ): 115 - 22 .

Swinson B , Jerjes W , El-Maaytah M , Norris P , Hopper C . Optical techniques in diagnosis of head and neck malignancy . Oral Oncol . 2006 ; 42 ( 3 ): 221 - 8 .

Mahadevan-Jansen A , Richards-Kortum RR . Raman spectroscopy for the detection of cancers and precancers . J Biomed Opt . 1996 ; 1 ( 1 ): 31 - 70 .

Ram S , Siar CH . Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions . Int J Oral Maxillofac Surg . 2005 ; 34 ( 5 ): 521 - 7 .

Trullenque-Eriksson A , Muñoz-Corcuera M , Campo-Trapero J , Cano-Sánchez J , Bascones-Martínez A . Analysis of new diagnostic methods in suspicious lesions of the oral mucosa . Med Oral Patol Oral Cir Bucal . 2009 ; 14 ( 5 ): E210 - 6 .

Mehrotra R , Singh M , Thomas S , Nair P , Pandya S , Nigam NS , et al . A cross-sectional study evaluating chemiluminescence and autofluorescence in the detection of clinically innocuous precancerous and cancerous oral lesions . J Am Dent Assoc . 2010 ; 141 ( 2 ): 151 - 6 .

Özyurt C , Uludağ İ , İnce B , Sezgintürk M K . Lab-on-a-chip systems for cancer biomarker diagnosis . J Pharm Biomed Anal . 2023 ; 226 : 115266 .

Balapure A , Dubey SK , Javed A , Chattopadhyay S , Goel S . A review: early detection of oral cancer biomarkers using microfluidic colorimetric point-of-care devices . Anal Methods . 2024 ; 16 ( 36 ): 6098 - 118 .

Pillai S , Kwan JC , Yaziji F , Yu H , Tran SD . Mapping the potential of microfluidics in early diagnosis and personalized treatment of head and neck cancers . Cancers . 2023 ; 15 ( 15 ): 3894 .

Ankri R , Ashkenazy A , Milstein Y , Brami Y , OlshinkaA , Goldenberg-Cohen N , et al . Gold nanorods based air scanning electron microscopy and diffusion reflection imaging for mapping tumor margins in squamous cell carcinoma . ACS Nano . 2016 ; 10 ( 2 ): 2349 - 56 .

Kah JCY , Kho KW , Lee CGL , Richard CJ , Sheppard , et al . Early diagnosis of oral cancer based on the surface plasmon resonance of gold nanoparticles . Int J Nanomedicine . 2007 ; 2 ( 4 ): 785 - 98 .

Jang SS , Davis ME , Vera DR , Lai SY , Guo TW . Role of sentinel lymph node biopsy for oral squamous cell carcinoma: current evidence and future challenges . Head Neck . 2023 ; 45 ( 1 ): 251 - 65 .

Luke GP , Myers JN , Emelianov SY , Sokolov KV . Sentinel lymph node biopsy revisited: ultrasound-guided photoacoustic detection of micrometastases using molecularly targeted plasmonic nanosensors . Cancer Res . 2014 ; 74 ( 19 ): 5397 - 408 .

Seetharam SS , Ramachandran CR . Fine needle aspiration cytology as a diagnostic test for oral squamous cell carcinoma . Oral Dis . 1998 ; 4 ( 3 ): 180 - 6 .

Scher RL , Oostingh PE , Levine PA , Cantrell RW , Feldman PS . Role of fine needle aspiration in the diagnosis of lesions of the oral cavity, oropharynx, and nasopharynx . Cancer . 1988 ; 62 ( 12 ): 2602 - 6 .

Epstein JB , Zhang LW , Rosin M . Advances in the diagnosis of oral premalignant and malignant lesions . J Can Dent Assoc . 2002 ; 68 ( 10 ): 617 - 21 .

Jordan RC , Daniels TE , Greenspan JS , Regezi JA . Advanced diagnostic methods in oral and maxillofacial pathology. Part I: molecular methods . Oral Surg Oral Med Oral Pathol Oral Radiol Endod . 2001 ; 92 ( 6 ): 650 - 69 .

Levsky JM , Singer RH . Fluorescence in situ hybridization: past, present and future . J Cell Sci . 2003 ; 116 ( 14 ): 2833 - 8 .

Mishra HK . Clinical applications of flow cytometry in cancer immunotherapies: from diagnosis to treatments . Methods Mol Biol . 2023 ; 2593 : 93 - 112 .

Schliephake H . Prognostic relevance of molecular markers of oral cancer – a review . Int J Oral Maxillofac Surg . 2003 ; 32 ( 3 ): 233 - 45 .

Kaczor-Urbanowicz KE , Martin Carreras-Presas C , Aro K , Tu M , Garcia-Godoy F , Wong DT , et al . Saliva diagnostics-Current views and directions . Exp Biol Med . 2017 ; 242 ( 5 ): 459 - 72 .

Cristaldi M , Mauceri R , Di Fede O , Giuliana G , Campisi G , Panzarella V , et al . Salivary biomarkers for oral squamous cell carcinoma diagnosis and follow-up: current status and perspectives . Front Physiol . 2019 ; 10 : 1476 .

Thierry AR , El Messaoudi S , Gahan PB , Anker P , Stroun M . Origins, structures, and functions of circulating DNA in oncology . Cancer Metastasis Rev . 2016 ; 35 ( 3 ): 347 - 76 .

Aulakh SS , Silverman DA , Young K , Dennis SK , Birkeland AC . The promise of circulating tumor DNA in head and neck cancer . Cancers . 2022 ; 14 ( 12 ): 2968 .

Di Meo A , Bartlett J , Cheng Y , Pasic MD , Yousef GM . Liquid biopsy: a step forward towards precision medicine in urologic malignancies . Mol Cancer . 2017 ; 16 ( 1 ): 80 .

Xu L , Li JH , Ye JM , Duan XN , Cheng YJ , Xin L , et al . A retrospective survival analysis of anatomic and prognostic stage group based on the American Joint Committee on Cancer 8th edition cancer staging manual in luminal B human epidermal growth factor receptor 2-negative breast cancer . Chin Med J . 2017 ; 130 ( 16 ): 1945 - 52 .

Zhang CZ , Cheng XQ , Li JY , Zhang P , Yi P , Xu X , et al . Saliva in the diagnosis of diseases . Int J Oral Sci . 2016 ; 8 ( 3 ): 133 - 7 .

Kaczor-Urbanowicz KE , Wei F , Rao SL , Kim J , Shin H , Cheng J , et al . Clinical validity of saliva and novel technology for cancer detection . Biochim Biophys Acta Rev Cancer . 2019 ; 1872 ( 1 ): 49 - 59 .

Kaufman E , Lamster IB . The diagnostic applications of saliva – a review . Crit Rev Oral Biol Med . 2002 ; 13 ( 2 ): 197 - 212 .

Gai C , Camussi F , Broccoletti R , Gambino A , Cabras M , Molinaro L , et al . Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma . BMC Cancer . 2018 ; 18 ( 1 ): 439 .

Khurshid Z , Zafar MS , Khan RS , Najeeb S , Slowey PD , Rehman IU , et al . Role of salivary biomarkers in oral cancer detection . Adv Clin Chem . 2018 ; 86 : 23 - 70 .

Mortazavi H , Yousefi-Koma AA , Yousefi-Koma H . Extensive comparison of salivary collection, transportation, preparation, and storage methods: a systematic review . BMC Oral Health . 2024 ; 24 ( 1 ): 168 .

Senevirathna K , Mahakapuge TAN , Jayawardana NU , Rajapakse J , Gamage CU , Seneviratne B , et al . Diagnostic potential of salivary IL-1β, IL-8, SAT, S100P, and OAZ1 in oral squamous cell carcinoma, oral submucous fibrosis, and oral lichen planus based on findings from a Sri Lankan cohort . Sci Rep . 2024 ; 14 ( 1 ): 27226 .

Czumbel LM , Kiss S , Farkas N , Mandel I , Hegyi A , Nagy Á , et al . Saliva as a candidate for COVID-19 diagnostic testing: a meta-analysis . Front Med . 2020 ; 7 : 465 .

Gleber-Netto FO , Yakob M , Li F , Feng Z , Dai J , Kao HK , et al . Salivary biomarkers for detection of oral squamous cell carcinoma in a Taiwanese population . Clin Cancer Res . 2016 ; 22 ( 13 ): 3340 - 7 .

Goldoni R , Scolaro A , Boccalari E , Dolci C , Scarano A , Inchingolo F , et al . Malignancies and biosensors: a focus on oral cancer detection through salivary biomarkers . Biosensors . 2021 ; 11 ( 10 ): 396 .

Radhika T , Jeddy N , Nithya S , Muthumeenakshi RM . Salivary biomarkers in oral squamous cell carcinoma–an insight . J Oral Biol Craniofacial Res . 2016 ; 6 : S51 - 4 .

Yakob M , Fuentes L , Wang MB , Abemayor E , Wong DT . Salivary biomarkers for detection of oral squamous cell carcinoma: current state and recent advances . Curr Oral Health Rep . 2014 ; 1 : 133 - 41 .

Mishra R . Glycogen synthase kinase 3 beta: can it be a target for oral cancer? . Mol Cancer . 2010 ; 9 : 144 .

Chu HW , Chang KP , Hsu CW , Chang IYF , Liu HP , Chen YT , et al . Identification of salivary biomarkers for oral cancer detection with untargeted and targeted quantitative proteomics approaches . Mol Cell Proteomics . 2019 ; 18 ( 9 ): 1796 - 806 .

da Costa NL , de Sá Alves M , de Sá Rodrigues N , Bandeira CM , Alves MGO , Mendes M A , et al . Finding the combination of multiple biomarkers to diagnose oral squamous cell carcinoma–a data mining approach . Comput Biol Med . 2022 ; 143 : 105296 .

Riccardi G , Bellizzi MG , Fatuzzo I , Zoccali F , Cavalcanti L , Greco A , et al . Salivary biomarkers in oral squamous cell carcinoma: a proteomic overview . Proteomes . 2022 ; 10 ( 4 ): 37 .

Mikkonen JJW , Singh SP , Akhi R , Salo T , Lappalainen R , González-Arriagada WA , et al . Potential role of nuclear magnetic resonance spectroscopy to identify salivary metabolite alte-rations in patients with head and neck cancer . Oncol Lett . 2018 ; 16 ( 5 ): 6795 - 800 .

Lepcha L , Kataki AC , Wankhar W , Unni BG . Protein profile of human saliva as a predictive and prognostic tool for OSCC in tamol chewer’s population in Assam . Asian Pac J Cancer Prev . 2021 ; 22 ( 6 ): 1837 - 41 .

Jaedicke KM , Taylor JJ , Preshaw PM . Validation and quality control of ELISAs for the use with human saliva samples . J Immunol Methods . 2012 ; 377 ( 1-2 ): 62 - 5 .

Sajan T , Murthy S , Krishnankutty R , Mitra J . A rapid, early detection of oral squamous cell carcinoma: real-time PCR-based detection of tetranectin . Mol Biol Res Commun . 2019 ; 8 ( 1 ): 33 - 40 .

Costa MM , Benoit N , Saby F , Pradines B , Granjeaud S , Almeras L , et al . Optimization and standardization of human saliva collection for MALDI-TOF MS . Diagnostics . 2021 ; 11 ( 8 ): 1304 .

Gardner A , Parkes HG , Carpenter GH , Therefore PW . Developing and standardizing a protocol for quantitative proton nuclear magnetic resonance (1H NMR) spectroscopy of saliva . J Proteome Res . 2018 ; 17 ( 4 ): 1521 - 31 .

Mandel P , Metais P . Nucleic acids of human blood plasma . C R Seances Soc Biol Fil . 1948 ; 142 ( 3-4 ): 241 - 3 .

Wang BG , Huang HY , Chen YC , Bristow RE , Kassauei K , Cheng CC , et al . Increased plasma DNA integrity in cancer patients . Cancer Res . 2003 ; 63 ( 14 ): 3966 - 8 .

Gao YJ , He YJ , Yang ZL , Shao HY , Zuo Y , Bai Y , et al . Increased integrity of circulating cell-free DNA in plasma of patients with acute leukemia . Clin Chem Lab Med . 2010 ; 48 ( 11 ): 1651 - 6 .

Ghiyasimoghaddam N , Shayan N , Mirkatuli HA , Baghbani M , Ameli N , Ashari Z , et al . Does circulating tumor DNA apply as a reliable biomarker for the diagnosis and prognosis of head and neck squamous cell carcinoma? . Discov Oncol . 2024 ; 15 ( 1 ): 427 .

Ferrier ST , Tsering T , Sadeghi N , Zeitouni A , Burnier JV . Blood and saliva‐derived ctDNA is a marker of residual disease after treatment and correlates with recurrence in human papillomavirus-associated head and neck cancer . Cancer Med . 2023 ; 12 ( 15 ): 15777 - 87 .

Hanna GJ , Dennis MJ , Scarfo N , Mullin MS , Sethi RK , Sehgal K , et al . Personalized ctDNA for monitoring disease status in head and neck squamous cell carcinoma . Clin Cancer Res . 2024 ; 30 ( 15 ): 3329 - 36 .

Perdomo S , Avogbe PH , Foll M , Abedi-Ardekani B , Facciolla VL , Anantharaman D , et al . Circulating tumor DNA detection in head and neck cancer: evaluation of two different detection approaches . Oncotarget . 2017 ; 8 ( 42 ): 72621 - 32 .

Sethi S , Benninger MS , Lu M , Havard S , Worsham MJ . Noninvasive molecular detection of head and neck squamous cell carcinoma: an exploratory analysis . Diagn Mol Pathol . 2009 ; 18 ( 2 ): 81 - 7 .

Eun YG , Yoon YJ , Won KY , Lee YC . Circulating tumor DNA in saliva in an orthotopic head and neck cancer mouse model . Anticancer Res . 2020 ; 40 ( 1 ): 191 - 9 .

Batur A , Novak R , Salai G , Hrkač S , Ćosić V , Grgurević L , et al . Extracellular vesicles in the pathogenesis and future diagnostics of oral squamous cell carcinoma . Future Sci OA . 2025 ; 11 ( 1 ): 2461940 .

Wang Q , Sun J , Jiang H , Yu M . Emerging roles of extracellular vesicles in oral and maxillofacial areas . Int J Oral Sci . 2025 ; 17 ( 1 ): 11 .

Balakittnen J , Ekanayake Weeramange C , Wallace DF , Duijf PH , Cristino AS , Hartel G , et al . A novel saliva-based miRNA profile to diagnose and predict oral cancer . Int J Oral Sci . 2024 ; 16 ( 1 ): 14 .

Manikandan M , Deva Magendhra Rao AK , Arunkumar G , Manickavasagam M , Rajkumar KS , Rajaraman R , et al . Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism . Mol Cancer . 2016 ; 15 : 28 .

Song H , Lai L , Liu M , Wang X , Zhang J , Zhang S , et al . Investigating the role and mechanism of microRNA-196a in oral squamous cell carcinoma by targeting FOXO1 . Exp Ther Med . 2020 ; 19 ( 6 ): 3707 - 15 .

Faur CI , Roman RC , Jurj A , Raduly L , Almășan O , Rotaru H , et al . Salivary exosomal microRNA-486-5p and microRNA-10b-5p in oral and oropharyngeal squamous cell carcinoma . Medicina . 2022 ; 58 ( 10 ): 1478 .

Singh R , Ha SE , Yu TY , Ro S . Dual roles of miR-10a-5p and miR-10b-5p as tumor suppressors and oncogenes in diverse cancers . Int J Mol Sci . 2025 ; 26 ( 1 ): 415 .

He L , Ping F , Fan Z , Zhang C , Deng M , Cheng B , et al . Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening . Biomed Pharmacother . 2020 ; 121 : 109553 .

Patel A , Patel S , Patel P , Mandlik D , Patel K , Tanavde V , et al . Salivary exosomal miRNA-1307-5p predicts disease aggressiveness and poor prognosis in oral squamous cell carcinoma patients . Int J Mol Sci . 2022 ; 23 ( 18 ): 10639 .

Farag AF , Sabry D , Hassabou NF , Alaa EL-Din Y . MicroRNA-134/microRNA-200a derived salivary exosomes are novel diagnostic biomarkers of oral squamous cell carcinoma . Egypt Dent J . 2021 ; 67 : 367 - 77 .

Chen CM , Chu TH , Chou CC , Chien CY , Wang JS , Huang CC , et al . Exosome-derived microRNAs in oral squamous cell carcinomas impact disease prognosis . Oral Oncol . 2021 ; 120 : 105402 .

He T , Guo X , Li X , Liao C , Wang X , He K , et al . Plasma‐derived exosomal microRNA‐130a serves as a noninvasive biomarker for diagnosis and prognosis of oral squamous cell carcinoma . J Oncol . 2021 ; 2021 : 5547911 .

Ludwig N , Yerneni SS , Harasymczuk M , Szczepański MJ , Głuszko A , Kukwa W , et al . TGFβ carrying exosomes in plasma: potential biomarkers of cancer progression in patients with head and neck squamous cell carcinoma . Br J Cancer . 2023 ; 128 ( 9 ): 1733 - 41 .

Wu T , Liu Y , Ali NM , Zhang B , Cui X . Effects of exosomes on tumor bioregulation and diagnosis . ACS Omega , 2023 ; 8 ( 6 ): 5157 - 68 .

Lipka A , Søland TM , Nieminen AI , Sapkota D , Haug TM , Galtung HK , et al . The effect of extracellular vesicles derived from oral squamous cell carcinoma on the metabolic profile of oral fibroblasts . Front Mol Biosci . 2025 ; 12 : 1492282 .

Yang E , Wang X , Gong Z , Yu M , Wu H , Zhang D . Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression . Signal Transduct Target Ther . 2020 ; 5 ( 1 ): 242 .

Zhao C , Zhang G , Liu J , Zhang C , Yao Y , Liao W , et al . Exosomal cargoes in OSCC: current findings and potential functions . PeerJ , 2020 ; 8 : e10062 .

Zhao B , Li Z , Li R . Exosomes in oral squamous cell carcinoma: functions, challenges, and potential applications . Front Oncol . 2025 ; 14 : 1502283 .

Patel A , Patel S , Patel P , Tanavde V . Saliva-based liquid biopsies in head and neck cancer: how far are we from the clinic? . Front Oncol . 2022 ; 12 : 828434 .

Stroun M , Lyautey J , Lederrey C , Olson-Sand A , Anker P . About the possible origin and mechanism of circulating DNA: apoptosis and active DNA release . Clin Chim Acta . 2001 ; 313 ( 1-2 ): 139 - 42 .

Haber DA , Velculescu VE . Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA . Cancer Discov . 2014 ; 4 ( 6 ): 650 - 61 .

Al-Malkey MK , Abbas AA , Khalaf NF , Mubarak IA , Jasim IA . Expression analysis of salivary microRNA-31 in oral cancer patients . Int J Curr Microbiol App Sci . 2015 ; 4 ( 12 ): 375 - 82 .

Zahran F , Ghalwash D , Shaker O , Al‐Johani K , Scully C . Salivary microRNAs in oral cancer . Oral Dis . 2015 ; 21 ( 6 ): 739 - 47 .

Alam Talukder MA , Huang Q , Shi J , Yanyu C , Guo Y , Zhang Q , et al . Emerging technologies in CTC detection: revolutionizing cancer management and treatment . J Nanotechnol . 2025 ; 2025 ( 1 ): 1391389 .

Huang L , Luo F , Deng M , Zhang J . The relationship between salivary cytokines and oral cancer and their diagnostic capability for oral cancer: a systematic review and network meta-analysis . BMC Oral Health . 2024 ; 24 ( 1 ): 1044 .

Singh P , Verma JK , Singh JK . Validation of salivary markers, IL-1β, IL-8 and Lgals3bp for detection of oral squamous cell carcinoma in an Indian population . Sci Rep . 2020 ; 10 ( 1 ): 7365 .

Deepthi G , Nandan SRK , Kulkarni PG . Salivary tumour necrosis factor-α as a biomarker in oral leukoplakia and oral squamous cell carcinoma . Asian Pac J Cancer Prev . 2019 ; 20 ( 7 ): 2087 - 93 .

Krishnan R , Thayalan DK , Padmanaban R , Ramadas R , Annasamy RK , Anandan N , et al . Association of serum and salivary tumor necrosis factor-α with histological grading in oral cancer and its role in differentiating premalignant and malignant oral disease . Asian Pac J Cancer Prev . 2014 ; 15 ( 17 ): 7141 - 8 .

Chen CJ , Sung WW , Su TC , Chen MK , Wu PR , Yeh KT , et al . High expression of interleukin 10 might predict poor prognosis in early-stage oral squamous cell carcinoma patients . Clin Chim Acta . 2013 ; 415 : 25 - 30 .

Zhang X , Yun JS , Han D , Yook JI , Kim HS , Cho ES , et al . TGF-β pathway in salivary gland fibrosis . Int J Mol Sci . 2020 ; 21 ( 23 ): 9138 .

Yang CM , Chen HC , Hou YY , Lee MC , Liou HH , Huang SJ , et al . A high IL-4 production diplotype is associated with an increased risk but better prognosis of oral and pharyngeal carcinomas . Arch Oral Biol . 2014 ; 59 ( 1 ): 35 - 46 .

Jiang L , Ma Z , Song L , Zhu C , Li J , Su Z , et al . Expression of interleukin-17 in oral tongue squamous cell carcinoma and its effect on biological behavior . Sci Rep . 2025 ; 15 ( 1 ): 3195 .

Nosratzehi T , Alijani E , Hassanpoor N . Evaluation of salivary interleukin-12, interleukin-23 levels in patients with oral lichen planus and squamous cell carcinoma . Eur J Gen Dent . 2021 ; 10 ( 2 ): 91 - 5 .

Fu Q , Liu X , Xia H , Li Y , Yu Z , Liu B , et al . Interferon-γ induces immunosuppression in salivary adenoid cystic carcinoma by regulating programmed death ligand 1 secretion . Int J Oral Sci . 2022 ; 14 ( 1 ): 47 .

Wolf A , Moissl-Eichinger C , Perras A , Koskinen K , Tomazic PV , Thurnher D , et al . The salivary microbiome as an indicator of carcinogenesis in patients with oropharyngeal squamous cell carcinoma: a pilot study . Sci Rep . 2017 ; 7 ( 1 ): 5867 .

Mivehchi H , Eskandari-Yaghbastlo A , Pour Bahrami P , Elhami A , Faghihinia F , Nejati ST , et al . Exploring the role of oral bacteria in oral cancer: a narrative review . Discov Oncol . 2025 ; 16 ( 1 ): 242 .

Wang J , Gao B . Mechanisms and potential clinical implications of oral microbiome in oral squamous cell carcinoma . Curr Oncol . 2023 ; 31 ( 1 ): 168 - 82 .

Sarkar P , Malik S , Laha S , Das S , Bunk S , Ray JG , et al . Dysbiosis of oral microbiota during oral squamous cell carcinoma development . Front Oncol . 2021 ; 11 : 614448 .

Li Z , Liu Y , Huang X , Wang Q , Fu R , Wen X , et al . F. nucleatum enhances oral squamous cell carcinoma proliferation via e-cadherin/β-catenin pathway . BMC Oral Health . 2024 ; 24 ( 1 ): 518 .

Zang W , Geng F , Liu J , Wang Z , Zhang S , Li Y , et al . Porphyromonas gingivalis potentiates stem-like properties of oral squamous cell carcinoma by modulating SCD1-dependent lipid synthesis via NOD1/KLF5 axis . Int J Oral Sci . 2025 ; 17 ( 1 ): 15 .

Peng RT , Sun Y , Zhou XD , Liu SY , Han Q , Cheng L , et al . Treponema denticola promotes OSCC development via the TGF-β signaling pathway . J Dent Res . 2022 ; 101 ( 6 ): 704 - 13 .

Boonanantanasarn K , Gill AL , Yap Y , Jayaprakash V , Sullivan MA , Gill SR , et al . Enterococcus faecalis enhances cell proliferation through hydrogen peroxide-mediated epidermal growth factor receptor activation . Infect Immun . 2012 ; 80 ( 10 ): 3545 - 58 .

Qin Y , Li Z , Liu T , Ma J , Liu H , Zhou Y , et al . Prevotella intermedia boosts OSCC progression through ISG15 upregulation: a new target for intervention . J Cancer Res Clin Oncol . 2024 ; 150 ( 4 ): 206 .

Agurto MG , Carpenter GH , Bozorgi SS , Koller G , Fenlon M , Warburton F , et al . Analysis of the association between salivary proteins and oral mucositis in patients with head and neck cancer undergoing IMRT: a longitudinal study . BMC Oral Health . 2024 ; 24 ( 1 ): 630 .

Almhöjd U , Cevik-Aras H , Karlsson N , Chuncheng J , Almståhl A . Stimulated saliva composition in patients with cancer of the head and neck region . BMC Oral Health . 2021 ; 21 ( 1 ): 509 .

Ramsay S , Hyvärinen E , González-Arriagada W , Salo T , Ajudarte Lopes M , Mikkonen JJ . et al . Radiation-induced changes in salivary metabolite profile and pathways in head and neck cancer patients . Clin Oral Investig . 2025 ; 29 ( 3 ): 1 - 11 .

Suragimath G , Patil S , Suragimath DG , Ashwinirani SR . Salivaomics: a revolutionary non-invasive approach for oral cancer detection . Cureus . 2024 ; 16 ( 11 ): e74381 .

Nonaka T , Wong DT . Saliva diagnostics: salivaomics, saliva exosomics, and saliva liquid biopsy . J Am Dent Assoc . 2023 ; 154 ( 8 ): 696 - 704 .

Adeoye J , Su YX . Artificial intelligence in salivary biomarker discovery and validation for oral diseases . Oral Dis . 2024 ; 30 ( 1 ): 23 - 37 .

Hunter B , Hindocha S , Lee RW . The role of artificial intelligence in early cancer diagnosis . Cancers . 2022 ; 14 ( 6 ): 1524 .

Liu J , Huang D , Cai Y , Cao Z , Liu Z , Zhang S , et al . Saliva diagnostics: emerging techniques and biomarkers for salivaomics in cancer detection . Expert Rev Mol Diagn . 2022 ; 22 ( 12 ): 1077 - 97 .

Ginghina O , Hudita A , Zamfir M , Spanu A , Mardare M , Bondoc I , et al . Liquid biopsy and artificial intelligence as tools to detect signatures of colorectal malignancies: a modern approach in patient’s stratification . Front Oncol . 2022 ; 12 : 856575 .

Fedorchak G , Rangnekar A , Onks C , Loeffert AC , Loeffert J , Olympia RP , et al . Saliva RNA biomarkers predict concussion duration and detect symptom recovery: a comparison with balance and cognitive testing . J Neurol . 2021 ; 268 ( 11 ): 4349 - 61 .

Sarker IH . Machine learning: algorithms, real-world applications and research directions . SN Comput Sci . 2021 ; 2 ( 3 ): 160 .

Song X , Yang X , Narayanan R , Shankar V , Ethiraj S , Wang X , et al . Oral squamous cell carcinoma diagnosed from saliva metabolic profiling . Proc Natl Acad Sci USA . 2020 ; 117 ( 28 ): 16167 - 73 .

Murata T , Yanagisawa T , Kurihara T , Kaneko M , Ota S , Enomoto A , et al . Salivary metabolomics with artificial intelligence-based methods for breast cancer detection and subtype prediction . Eur J Cancer . 2020 ; 138 : S18 .

Liu L , Chen X , Petinrin OO , Zhang W , Rahaman S , Tang ZR , et al . Machine learning protocols in early cancer detection based on liquid biopsy: a survey . Life . 2021 ; 11 ( 7 ): 638 .

Tseng YJ , Wang YC , Hsueh PC , Wu CC . Development and validation of machine learning-based risk prediction models of oral squamous cell carcinoma using salivary autoantibody biomarkers . BMC Oral Health . 2022 ; 22 ( 1 ): 534 .

Adeoye J , Wan CCJ , Zheng LW , Thomson P , Choi SW , Su YX , et al . Machine learning-based genome-wide salivary DNA methylation analysis for identification of noninvasive biomarkers in oral cancer diagnosis . Cancers . 2022 ; 14 ( 19 ): 4935 .

Wei F , Liao W , Xu Z , Yang Y , Wong DT , Ho CM , et al . Bio/abiotic interface constructed from nanoscale DNA dendrimer and conducting polymer for ultrasensitive biomolecular diagnosis . Small . 2009 ; 5 ( 15 ): 1784 - 90 .

Wei F , Wang J , Liao W , Zimmermann BG , Wong DT , Ho CM et al . Electrochemical detection of low-copy-number salivary RNA based on specific signal amplification with a hairpin probe . Nucleic Acids Res . 2008 ; 36 ( 11 ): e65 .

Tu M , Cheng J , Chen YL , Jea WC , Chen WL , Chen CJ , et al . Electric field-induced release and measurement (EFIRM): characterization and technical validation of a novel liquid biopsy platform in plasma and saliva . J Mol Diagn . 2020 ; 22 ( 8 ): 1050 - 62 .

Forbes SA , Beare D , Boutselakis H , Bamford S , Bindal N , Tate J , et al . COSMIC: somatic cancer genetics at high-resolution . Nucleic Acids Res . 2017 ; 45 ( D1 ): D777 - 83 .

Loomans-Kropp HA , Umar A , Minasian LM , Pinsky PF . Multi-cancer early detection tests: current progress and future perspectives . Cancer Epidemiol Biomarkers Prev . 2022 ; 31 ( 3 ): 512 - 14 .

Kim C , Xi L , Cultraro CM , Wei F , Jones G , Cheng J , et al . Longitudinal circulating tumor DNA analysis in blood and saliva for prediction of response to osimertinib and disease progression in EGFR-mutant lung adenocarcinoma . Cancers . 2021 ; 13 ( 13 ): 3342 .

Yuan H , Gao W , Yin J , Chen K , Mu Y , Jin Q , et al . Detection of EGFR gene with a droplet digital PCR chip integrating a double-layer glass reservoir . Anal Biochem . 2022 ; 656 : 114877 .

Li F , Wei F , Liao W , Huang WL , Lin CC , Chia D , et al . EFIRM liquid biopsy (eLB): detection of ultra-short circulating tumor DNA (usctDNA) in plasma and saliva of non-small cell lung cancer (NSCLC) patients . J Clin Oncol . 2018 ; 36 ( 15_suppl ): e24062 .

Hindson BJ , Ness KD , Masquelier DA , Belgrader P , Heredia NJ , Makarewicz AJ , et al . High-throughput droplet digital PCR system for absolute quantitation of DNA copy number . Anal Chem . 2011 ; 83 ( 22 ): 8604 - 10 .

Hisano O , Ito T , Miura F . Short single-stranded DNAs with putative non-canonical structures comprise a new class of plasma cell-free DNA . BMC Biol . 2021 ; 19 ( 1 ): 225 .

Gurung S , Perocheau D , Touramanidou L , Baruteau J . The exosome journey: from biogenesis to uptake and intracellular signalling . Cell Commun Signal . 2021 ; 19 ( 1 ): 47 .

Bano A , Vats R , Yadav P , Bhardwaj R . Exosomics in oral cancer diagnosis, prognosis, and therapeutics–an emergent and imperative non-invasive natural nanoparticle-based approach . Crit Rev Oncol Hematol . 2022 ; 178 : 103799 .

Cheng J , Morselli M , Huang WL , Heo YJ , Pinheiro-Ferreira T , Li F , et al . Plasma contains ultrashort single-stranded DNA in addition to nucleosomal cell-free DNA . iScience . 2022 ; 25 ( 7 ): 104554 .

Cheng LY , Dai P , Wu LR , Patel AA , Zhang DY . Direct capture and sequencing reveal ultra-short single-stranded DNA in biofluids . iScience . 2022 ; 25 ( 10 ): 105046 .

Hudecova I , Smith CG , Hänsel-Hertsch R , Chilamakuri CS , Morris JA , Vijayaraghavan A , et al . Characteristics, origin, and potential for cancer diagnostics of ultrashort plasma cell-free DNA . Genome Res . 2022 ; 32 ( 2 ): 215 - 27 .

Mattox AK , Douville C , Wang Y , Popoli M , Ptak J , Silliman N , et al . The origin of highly elevated cell-free DNA in healthy individuals and patients with pancreatic, colorectal, lung, or ovarian cancer . Cancer Discov . 2023 ; 13 ( 10 ): 2166 - 79 .

Yu JS , Chen YT , Chiang WF , Hsiao YC , Chu LJ , See LC , et al . Saliva protein biomarkers to detect oral squamous cell carcinoma in a high-risk population in Taiwan . Proc Natl Acad Sci U S A . 2016 ; 113 ( 41 ): 11549 - 54 .

Raslan S , Smith DH , Reis IM , Peifer SJ , Forman G , Ezeh UC , et al . Soluble CD44 in oral rinses for the early detection of cancer: a prospective cohort study in high-risk individuals . BMC Oral Health . 2024 ; 24 ( 1 ): 820 .

Arellano‐Garcia ME , Hu S , Wang J , Henson B , Zhou H , Chia D , et al . Multiplexed immunobead‐based assay for detection of oral cancer protein biomarkers in saliva . Oral Dis . 2008 ; 14 ( 8 ): 705 - 12 .

Kumar P , Singh K , Garg A , Urs AB , Augustine J . Salivary IL-8, CYFRA 21-1, and CD44 for early detection of oral squamous cell carcinoma: a systematic review and meta-analysis . Clin Chim Acta . 2025 ; 577 : 120471 .

Rhodus NL , Ho V , Miller CS , Myers S , Ondrey F . NF-κB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma . Cancer Detect Prev . 2005 ; 29 ( 1 ): 42 - 45 .

Franzmann EJ , Reategui EP , Pedroso F , Pernas FG , Karakullukcu BM , Carraway KL , et al . Soluble CD44 is a potential marker for the early detection of head and neck cancer . Cancer Epidemiol Biomarkers Prev . 2007 ; 16 ( 7 ): 1348 - 55 .

Park NJ , Zhou H , Elashoff D , Henson BS , Kastratovic DA , Abemayor E , et al . Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection . Clin Cancer Res . 2009 ; 15 ( 17 ): 5473 - 77 .

Momen-Heravi F , Trachtenberg AJ , Kuo WP , Cheng YS . Genome-wide study of salivary microRNAs for detection of oral cancer . J Dent Res . 2014 ; 93 ( 7_suppl ): 86S - 93S .

Wong TS , Liu XB , Wong BYH , Ng RWM , Yuen APW , Wei WI , et al . Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue . Clin Cancer Res . 2008 ; 14 ( 9 ): 2588 - 92 .

Nagler R , Bahar G , Shpitzer T , Feinmesser R . Concomitant analysis of salivary tumor markers–a new diagnostic tool for oral cancer . Clin Cancer Res . 2006 ; 12 ( 13 ): 3979 - 84 .

Wang Y , Springer S , Mulvey CL , Silliman N , Schaefer J , Sausen M , et al . Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas . Sci Transl Med . 2015 ; 7 ( 293 ): 293ra104 .

Boyle JO , Hakim J , Koch W , Riet PVD , Hruban RH , Roa RA , et al . The incidence of p53 mutations increases with progression of head and neck cancer . Cancer Res . 1993 ; 53 ( 19 ): 4477 - 80 .

Li Y , St John MA , Zhou X , Kim Y , Sinha U , Jordan RC , Eisele D , et al . Salivary transcriptome diagnostics for oral cancer detection . Clin Cancer Res . 2004 ; 10 ( 24 ): 8442 - 50 .

Khijmatgar S , Yong J , Rübsamen N , Lorusso F , Rai P , Cenzato N , et al . Salivary biomarkers for early detection of oral squamous cell carcinoma (OSCC) and head/neck squamous cell carcinoma (HNSCC): a systematic review and network meta-analysis . Jpn Dent Sci Rev . 2024 ; 60 : 32 - 9 .

Gao J , Zhang L , Peng K , Sun H . Diagnostic value of serum tumor markers CEA, CYFRA21-1, SCCAg, NSE, and ProGRP for lung cancers of different pathological types . Nan Fang Yi Ke Da Xue Xue Bao . 2022 ; 42 ( 6 ): 886 - 91 .

Farah CS , McCullough MJ , Harrison P . A review of research on salivary biomarkers for oral cancer detection . J Oral Pathol Med . 2013 ; 42 ( 11 ): 819 - 28 .

Bastías D , Maturana A , Marin C , Martínez R , Niklander SE . Salivary biomarkers for oral cancer detection: an exploratory systematic review . Int J Mol Sci . 2024 ; 25 ( 5 ): 2634 .

Constantin V , Luchian I , Goriuc A , Budala DG , Bida FC , Cojocaru C , et al . Salivary biomarkers identification: advances in standard and emerging technologies . Oral . 2025 ; 5 ( 2 ): 26 .

Antonelli R , Setti G , Treister NS , Pertinhez TA , Ferrari E , Gallo M , et al . Salivary metabolomics in oral cancer: a systematic review . Oral Oncol Rep . 2024 ; 11 : 100657 .

Okuyama K , Yanamoto S . Saliva in balancing oral and systemic health, oral cancer, and beyond: a narrative review . Cancers . 2024 ; 16 ( 24 ): 4276 .

Revuelta-López E , Barallat J , Cserkóová A , Gálvez-Montón C , Jaffe AS , Januzzi JL , et al . Pre-analytical considerations in biomarker research: focus on cardiovascular disease . Clin Chem Lab Med . 2021 ; 59 ( 11 ): 1747 - 60 .

Li Y , Ou Y , Fan K , Liu G . Salivary diagnostics: opportunities and challenges . Theranostics . 2024 ; 14 ( 18 ): 6969 .

Liao C , Chen X , Fu Y . Salivary analysis: an emerging paradigm for non‐invasive healthcare diagnosis and monitoring . Interdiscip Med . 2023 ; 1 ( 3 ): e20230009 .

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

PRIME: an interpretable artificial intelligence model based on liquid biopsy improves prediction of progression risk in non-small cell lung cancer

Cell-free DNA in sepsis: from molecular insights to clinical management